Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

PEO-generated Surfaces Support Attachment and Growth of Cells In Vitro with No Additional Benefit for Micro-roughness in Sa (0.2-4 μm)

OLE JUNG, RALF SMEETS, ALEXANDER KOPP, DARIO PORCHETTA, PHILIPP HIESTER, MAX HEILAND, REINHARD E. FRIEDRICH, CLARISSA PRECHT, HENNING HANKEN, ALEXANDER GRÖBE and PHILIP HARTJEN
In Vivo January 2016, 30 (1) 27-33;
OLE JUNG
1Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ol.jung{at}uke.de
RALF SMEETS
1Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALEXANDER KOPP
2Meotec GmbH & Co. KG, Aachen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DARIO PORCHETTA
2Meotec GmbH & Co. KG, Aachen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PHILIPP HIESTER
2Meotec GmbH & Co. KG, Aachen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAX HEILAND
1Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
REINHARD E. FRIEDRICH
1Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CLARISSA PRECHT
1Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HENNING HANKEN
1Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALEXANDER GRÖBE
1Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PHILIP HARTJEN
1Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: Plasma electrolytic oxidation (PEO), also known as micro-arc oxidation, is a promising electrochemical surface treatment technique for metals which has been used for the generation of various material surfaces and has been the focus of recent biomaterial research. It has been hypothesized that rough PEO surfaces should generally have properties that support cellular attachment and proliferation. However, this has not yet been demonstrated in systematically conducted studies. The present study investigated fibroblast cell proliferation and attachment to ground, electric discharge machining (EDM) and PEO-treated titanium surfaces differing in roughness and porosity. Materials and Methods: Three surface variants with ‘smoother’, ‘medium-coarse’ and ‘rough’ surface topographies were generated by PEO and EDM on specimens of titanium alloy (with 6 wt% aluminum and 4 wt% vanadium) for comparison with more smoothly ground specimens. The in vitro effects on cellular attachment and proliferation were determined in 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT), 5-bromo-2’-deoxyuridine (BrdU) and live/dead staining assays with L929 fibroblasts cultivated directly on the metal specimens. Cytocompatibility was determined in accordance with DIN 10993-5/-12 regulations by extract assays. Results: Besides cytocompatibility, all PEO specimens exhibited similar biocompatibility and attachment properties, with vital, spindle-shaped adherent cells growing on the surface, regardless of their surface topology. There were no significant differences in cellular proliferation between the different surfaces and negative controls (cells growing in cell-culture plates). Discussion/Conclusion: With no differences in cellular proliferation and attachment between PEO surfaces with different roughness, we find no evidence to support the notion that rougher PEO surfaces are more favorable for cellular growth of fibroblasts in vitro.

  • Plasma electrolytic oxidation
  • PEO
  • roughness
  • surface topography
  • cell adhesion
  • cell growth

Biomaterials are becoming increasingly important in everyday medical practice and research. Various products with different specifications and applications are available today. The ideal bone replacement material has osteoinductive, osteoconductive and osteopromoting properties in addition to long-term stability and excellent biocompatibility. The surface characteristics of bone replacement materials and other biomaterials are crucial for their bioactive properties and are directly dependent on the manufacturing process and the material composition. Furthermore, the biocompatibility of biomaterial surfaces is of particular importance as the surface represents the interface between material and tissue/bone.

Plasma electrolytic oxidation (PEO), also known as micro-arc oxidation, is an electrochemical surface treatment technique for metals that allows the manufacture of biocompatible and bioactive titanium surfaces that are better suited for cellular attachment and growth than conventional titanium surfaces (1-3).

Numerous studies describe favorable bioactivity of rough and porous surfaces (4-15). Roughness and porosity are two interdependent surface characteristics of bioactive surfaces that result from the manufacturing process used. The superior properties of roughened surfaces ascribed to other manufacturing processes have also been attributed to PEO surfaces, but the characteristics underlying their bioactivity have not yet been verified in systematic investigations. Overall, it is not sufficiently clear whether and to what degree the bioactive effects are based on the roughness, coating or manufacturing method, physicochemical composition, or on all variables of PEO-treated surfaces.

With this study, we aimed to evaluate the bioactivity and surface characteristics of PEO-treated titanium surfaces of different roughness in vitro by measuring influences on cellular adhesion, proliferation, morphology and overall viability of cells cultured on PEO surfaces compared with untreated controls.

Materials and Methods

Materials and surface treatment. For the experiments, the commercially available alpha/beta alloy Ti6Al4V (grade 4 and 5) was used. The alloy contains titanium with 6 wt% aluminum and 4 wt% vanadium. Disc-shaped specimens of 18 mm diameter and 1 mm thickness were cut from a rod using electrical discharge machining (ADM) (AQ537L; Sodick, Duesseldorf, Germany). After polishing with silicon carbide paper (600 grit), the specimens were washed in ethanol for 10 min and in 15% HF/30% HNO3 for 15 s in order to remove oxide layers resulting from cutting and polishing. Finally, all samples were washed with distilled water for 15 min in an ultrasonic bath and dried on a sterile blanket at room temperature.

Plasma electrolytic oxidation. PEO was achieved using a pulsed rectifier set (M-PEO A1; Meotec, Aachen, Germany). Different electrolytic compositions were prepared for the coating process (Table I). Positive and negative pulsed directed currents of 2 A and 3 A with voltages from 0 V to 500 V were applied by two feed cables. The electrochemical cell consisted of a titanium specimen as anode and platinum mesh as cathode. Pulse frequency was set to 20 Hz and discs were treated for up to 15 min. After processing, all samples were rinsed with distilled water in an ultrasonic bath for 15 min and dried on a sterile blanket at room temperature.

Physical and chemical characterization of the surfaces. The coated surfaces were imaged by scanning electron microscopy (SEM) (XL30 CP; Philips, Amsterdam, the Netherlands) and energy-dispersive X-ray spectroscopy (EDX). 3-D structures and roughness of coated surfaces were characterized using a non-contact optical 3-D profilometer (ZygoLOT ZeGage; AMETEK GmbH, Wiesbaden, Germany).

Experimental groups. Five samples displaying different surface compositions and roughness were prepared (Table I). Untreated samples were used as reference or control group. RM-A, a polyurethane film containing 0.1% zinc diethyldithiocarbamate (Hatano Research Institute, Food and Drug Safety Center, Japan), was used as a positive control reference material. Cells directly seeded onto the surface of the well-plates were used as negative control.

Cell culture. Cell culture was accomplished with L929 fibroblasts (LGC Standards, Wesel, Germany) in minimum essential medium (Life Technologies, Carlsbad, USA; further referred to as cell culture medium) with 10% fetal calf serum (Gibco, Darmstadt, Germany), 1% Penstrep (Gibco, Darmstadt, Germany) and 4 mmol L-glutamine (Sigma-Aldrich, St. Louis, MO, USA) at 37°C, with 21% O2, 5% CO2 and 95% humidity (innova CO-48-230; New Brunswick Scientific, Enflied, CT, USA) hereafter referred to as cell culture condtions. Cell passaging was accomplished at 70-80% cell confluence. For the experiments, cells between the 5th and 10th passage were used.

In vitro characterization of the test samples. Experiments and settings were applied as described in detail in our previous work (16), except that the assay volume was 1 ml in the direct test scheme. If applicable, all tests (direct, extract-based and live/dead staining) were carried out in accordance with DIN ISO 10993-5/-12 regulations.

Specimen sterilization. All samples were sterilized by immersion in 2-propanol for 5 min within a laminar floor hood (Microflow Biological Safety Cabinet). Using sterile gloves, the samples were dried on a sterile blanket and placed in sterile 12-well plates.

Extract and direct tests. All experiments were repeated twice. For the extract tests, four specimens from each group were extracted in 1.88 ml/cm2 cell culture medium and under cell culture conditions for 72 h in 12-well plates. The resulting extracts were centrifuged at 21,952 × g for 15 min. 96-Well plates (Sarstedt, Nürmbrecht, Germany) were seeded with 1×104 L-929 cells/well in 100 μl cell culture medium and incubated under cell culture condition 24 h before the end of the extraction process. Subsequently, the cell culture medium was discarded and 100 μl extract of each sample was equally divided among four wells. Assays were carried out after 24 h incubation with extract under cell culture conditions.

Direct assays were accomplished by directly seeding 5×104 fibroblasts onto the surface of the test specimens in 12-well plates. After 24 h incubation, the test specimens were washed in PBS at 37°C to remove residues and assays were carried out as described below.

XTT assay. Cell Proliferation Kit II (XTT) (Roche Diagnostics, Mannheim, Germany) was used according to the manufacturer's instructions. The included electron-coupling reagent was briefly mixed with XTT labeling reagent (1:50 dilution) and added to the wells. After 4 h, the absorbance was measured by an enzyme-linked immunosorbent assay (ELISA) plate reader with filters for 450 nm and 650 nm (reference wavelength).

Bromodeoxyuridine (BrdU) assay. Cell Proliferation ELISA, BrdU (colorimetric) test kit (Roche Diagnostics) was used according to the manufacturer's instructions. A recommended background check was conducted.

Briefly, the cells were labeled with BrdU for 2 h under cell culture conditions and subsequently fixed for 30 min at room temperature with FixDenat reagent from the kit. Following anti-BrdU-POD incubation at room temperature for 1 h, wells were washed three times with incubation times of 5 min with PBS. Tetramethyl-benzidine substrate was then added and the wells incubated for 20 min at room temperature. The reaction was stopped by the addition of 25 μl 1 M H2SO4 to each well. Subsequently, absorbance of wells was determined by an ELISA plate reader with filters for 450 nm and 690 nm (reference wavelength).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Overview of the test materials with corresponding electrolytic composition and roughness.

Live/dead cell staining. Cell adhesion and morphology can be directly visualized by live/dead staining, visible as green (living) and red (dead) fluorescence of cells.

12-Well plates (Sarstedt) were seeded with 240,000 fibroblasts in 1 ml cell medium and incubated for 24 h under cell culture conditions. Then, 60 μl propidium iodide (PI) stock solution (50 μg/ml in PBS) and 500 μl fresh fluorescein diacetate (FDA) working solution (20 μg/ml in PBS from 5 mg/ml FDA in acetone stock solution) was added to the prepared 12-well plates. After 3 min incubation at room temperature, the specimens were rinsed in Dulbecco's phosphate buffered saline (DPBS, Life Technologies, Carlsbad, USA) at 37°C and the surface immediately examined with an upright fluorescence microscope (Nikon ECLIPSE Ti-S/L100; Nikon GmbH, Düsseldorf, Germany). Red and green fluorescence was accomplished by use of appropriate filters.

Data evaluation and statistical analysis. All results were transferred to and encoded in Microsoft Excel 2010 (Microsoft, Redmond, Washington, USA) and GraphPad Prism 5.0 (GraphPad Software, San Diego, CA, USA). Statistical analysis was performed using SPSS 21 (IBM, New York, NY, USA).

The mean absorbance of blank controls (cell culture medium without cells) was calculated and used as the baseline. After subtracting the baseline, the mean absorbance and standard deviation were calculated from the corresponding replicates for each test material and control. The mean absorbance of test materials was normalized against that of the negative controls.

Differences were analyzed using one-way ANOVA with appropriate post hoc Scheffé or Games-Howell procedures. p-Values of 0.05 or less were considered statistically significant. Deviations of 30% in viability were considered cytotoxic according to EN ISO 10993-5.

Results

Surface characterization. We manufactured three different rough PEO surfaces on TiAl6V4. Results from SEM/EDX and profilometry are demonstrated in Figure 1.

As expected, peaks of titanium, aluminum and vanadium were visualized on all test samples. Residues of copper were considered to be a result of EDM. The surface roughness of the test and control samples differed from 0.2-4 μm. The porosity of the surfaces increases with higher roughness.

In vitro tests. Regardless of the surface treatment method and roughness, all test materials were covered with large numbers of green FDA-positive vital cells in the live/dead staining assays. Suggesting improved adhesion, the cell morphology on all test samples was predominantly spindle-shaped (Figure 2). No dead cells were observed on the test materials.

Cell viability and proliferation results were on the same level or slightly higher than that of the negative controls in all direct as well as indirect XTT assays (Figure 2). The indirect BrdU assay showed significant differences between the untreated sample and PEO-treated samples. However, the results did not exceed the cytotoxic range.

Discussion

The present study aimed to evaluate the influence of PEO-treated titanium surfaces with different roughness in vitro by measuring possible influences on cellular adhesion, proliferation, morphology and overall viability of cells cultured on PEO-treated surfaces and of untreated controls. When applicable, cell-based assays were applied according to DIN ISO 10993-5/-12 regulations.

In a first step, we successfully manufactured titanium test samples with three PEO-treated surfaces of different roughness. Further test results revealed no significant differences in terms of cellular adhesion, proliferation and morphology between the different rough surfaces and the negative controls. However, cells seeded onto PEO-treated surfaces showed better attachment and there were more spindle-shaped cells than on the untreated materials. All indirect cytocompatibility results were within the non-toxic range for the PEO-treated and untreated test samples. We conclude that an increase in surface area and roughness of PEO-treated materials does not automatically improve cellular performance.

The indicated negligible differences in cell behavior between rough and smooth surfaces were also identified by Ramaglia et al., who applied an acid etching procedure for surface roughening (12). Various other studies investigated a positive influence of material roughness on cellular adhesion, proliferation and differentiation (3-6, 9-11, 13, 15, 17). Although the results were mostly better for rougher surfaces, no comparisons bewteen different rough surfaces of the same origin were made. In our opinion, surface roughness does not automatically result in better cell performance and should be investigated individually for each individual coating technique.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Physical surface characterization of untreated materials (A) and materials after (B-D; as described in Table I) plasma electrolytic oxidation (PEO) coating. Scanning electron microscopy (left) and energy dispersive X-ray spectroscopy (right) images demonstrate the surface topography and composition. Profilometry (middle) gives an exact value for the achieved roughness.

The methods applied in the present study represent only fundamental techniques. Further studies should also investigate cellular differentiation by more specific methods (e.g. immunohistochemistry, immunofluorescence). Thereby, an additional osteoblastic cell line should be implemented. Similarly to our study, a suitable control (e.g. untreated or uncoated sample) should be always part of a comparative study.

Conclusion

In an effort to manufacture different rough PEO samples for identifying the impact of surface roughness on cellular adhesion, proliferation and morphology, the compared compared plasma electrolytic oxidized surfaces to conventional smoother grinded titanium samples. Thereby, no differences between the different PEO samples could be detected. However, PEO alone seems to improve cellular attachment. Overall, the PEO coating technique demonstrated attractive features for the further use on biomedical products.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

In vitro results for the test materials A: Live (green)/dead (red) staining images; B: proliferative assay; C: cytocompatibility assay showing relative cell viability. *Significantly different from the negative control samples at p≤0.05. Materials: A: untreated; B-D: after plasma electrolytic oxidation (PEO) coating; PC: positive control.

Acknowledgements

This study was funded by the Bundesministerium für Bildung und Forschung, BMBF (FKZ 0316206A-C, BIOMAGIK). This work is the result of the collaboration within the BIOMAGIK consortium.

Footnotes

  • ↵* These Authors contributed equally to this study.

  • Conflicts of Interest

    AK, PH and DP are employed by the Meotec GmbH & Co. KG, a company that is specialized in electrochemical surface treatment of metals. Meotec manufactured the test materials and performed the PEO-coating technology in this study.

  • Received September 28, 2015.
  • Revision received November 29, 2015.
  • Accepted December 2, 2015.
  • Copyright © 2016 The Author(s). Published by the International Institute of Anticancer Research.

References

  1. ↵
    1. Chen GJ,
    2. Wang Z,
    3. Bai H,
    4. Li JM,
    5. Cai H
    : A preliminary study on investigating the attachment of soft tissue onto micro-arc oxidized titanium alloy implants. Biomed Mater (Bristol, England) 4(1): 015017, 2009.
    OpenUrl
    1. Chen J-z,
    2. Peng H-y,
    3. Zhang X-l
    : Effects of the micro-arc oxidized film on pure titanium surface on attachment and growth of bmscs. Shanghai Kou Qiang Yi Xue=Shanghai journal of stomatology 18(1): 81-85, 2009.
    OpenUrl
  2. ↵
    1. Zhang YM,
    2. Bataillon-Linez P,
    3. Huang P,
    4. Zhao YM,
    5. Han Y,
    6. Traisnel M,
    7. Xu KW,
    8. Hildebrand HF
    : Surface analyses of micro-arc oxidized and hydrothermally treated titanium and effect on osteoblast behavior. J Biomed Mater Res A 68(2): 383-391, 2004.
    OpenUrlPubMed
  3. ↵
    1. Das K,
    2. Bose S,
    3. Bandyopadhyay A
    : Surface modifications and cell-materials interactions with anodized ti. Acta Biomater 3(4): 573-585, 2007.
    OpenUrlCrossRefPubMed
    1. Aubert B,
    2. Bona M,
    3. Karyotakis Y,
    4. Lees JP,
    5. Poireau V,
    6. Prencipe E,
    7. Prudent X,
    8. Tisserand V,
    9. Garra Tico J,
    10. Grauges E,
    11. Lopez L,
    12. Palano A,
    13. Pappagallo M,
    14. Eigen G,
    15. Stugu B,
    16. Sun L,
    17. Abrams GS,
    18. Battaglia M,
    19. Brown DN,
    20. Cahn RN,
    21. Jacobsen RG,
    22. Kerth LT,
    23. Kolomensky YG,
    24. Lynch G,
    25. Osipenkov IL,
    26. Ronan MT,
    27. Tackmann K,
    28. Tanabe T,
    29. Hawkes CM,
    30. Soni N,
    31. Watson AT,
    32. Koch H,
    33. Schroeder T,
    34. Walker D,
    35. Asgeirsson DJ,
    36. Fulsom BG,
    37. Hearty C,
    38. Mattison TS,
    39. McKenna JA,
    40. Barrett M,
    41. Khan A,
    42. Blinov VE,
    43. Bukin AD,
    44. Buzykaev AR,
    45. Druzhinin VP,
    46. Golubev VB,
    47. Onuchin AP,
    48. Serednyakov SI,
    49. Skovpen YI,
    50. Solodov EP,
    51. Todyshev KY,
    52. Bondioli M,
    53. Curry S,
    54. Eschrich I,
    55. Kirkby D,
    56. Lankford AJ,
    57. Lund P,
    58. Mandelkern M,
    59. Martin EC,
    60. Stoker DP,
    61. Abachi S,
    62. Buchanan C,
    63. Gary JW,
    64. Liu F,
    65. Long O,
    66. Shen BC,
    67. Vitug GM,
    68. Yasin Z,
    69. Zhang L,
    70. Sharma V,
    71. Campagnari C,
    72. Hong TM,
    73. Kovalskyi D,
    74. Mazur MA,
    75. Richman JD,
    76. Beck TW,
    77. Eisner AM,
    78. Flacco CJ,
    79. Heusch CA,
    80. Kroseberg J,
    81. Lockman WS,
    82. Martinez AJ,
    83. Schalk T,
    84. Schumm BA,
    85. Seiden A,
    86. Wilson MG,
    87. Winstrom LO,
    88. Cheng CH,
    89. Doll DA,
    90. Echenard B,
    91. Fang F,
    92. Hitlin DG,
    93. Narsky I,
    94. Piatenko T,
    95. Porter FC,
    96. Andreassen R,
    97. Mancinelli G,
    98. Meadows BT,
    99. Mishra K,
    100. Sokoloff MD,
    101. Bloom PC,
    102. Ford WT,
    103. Gaz A,
    104. Hirschauer JF,
    105. Nagel M,
    106. Nauenberg U,
    107. Smith JG,
    108. Ulmer KA,
    109. Wagner SR,
    110. Ayad R,
    111. Soffer A,
    112. Toki WH,
    113. Wilson RJ,
    114. Altenburg DD,
    115. Feltresi E,
    116. Hauke A,
    117. Jasper H,
    118. Karbach M,
    119. Merkel J,
    120. Petzold A,
    121. Spaan B,
    122. Wacker K,
    123. Kobel MJ,
    124. Mader WF,
    125. Nogowski R,
    126. Schubert KR,
    127. Schwierz R,
    128. Volk A,
    129. Bernard D,
    130. Bonneaud GR,
    131. Latour E,
    132. Verderi M,
    133. Clark PJ,
    134. Playfer S,
    135. Watson JE,
    136. Andreotti M,
    137. Bettoni D,
    138. Bozzi C,
    139. Calabrese R,
    140. Cecchi A,
    141. Cibinetto G,
    142. Franchini P,
    143. Luppi E,
    144. Negrini M,
    145. Petrella A,
    146. Piemontese L,
    147. Santoro V,
    148. Baldini-Ferroli R,
    149. Calcaterra A,
    150. de Sangro R,
    151. Finocchiaro G,
    152. Pacetti S,
    153. Patteri P,
    154. Peruzzi IM,
    155. Piccolo M,
    156. Rama M,
    157. Zallo A,
    158. Buzzo A,
    159. Contri R,
    160. Lo Vetere M,
    161. Macri MM,
    162. Monge MR,
    163. Passaggio S,
    164. Patrignani C,
    165. Robutti E,
    166. Santroni A,
    167. Tosi S,
    168. Chaisanguanthum KS,
    169. Morii M,
    170. Adametz A,
    171. Marks J,
    172. Schenk S,
    173. Uwer U,
    174. Klose V,
    175. Lacker HM,
    176. Bard DJ,
    177. Dauncey PD,
    178. Nash JA,
    179. Tibbetts M,
    180. Behera PK,
    181. Chai X,
    182. Charles MJ,
    183. Mallik U,
    184. Cochran J,
    185. Crawley HB,
    186. Dong L,
    187. Meyer WT,
    188. Prell S,
    189. Rosenberg EI,
    190. Rubin AE,
    191. Gao YY,
    192. Gritsan AV,
    193. Guo ZJ,
    194. Lae CK,
    195. Arnaud N,
    196. Bequilleux J,
    197. D'Orazio A,
    198. Davier M,
    199. Firmino da Costa J,
    200. Grosdidier G,
    201. Hocker A,
    202. Lepeltier V,
    203. Le Diberder F,
    204. Lutz AM,
    205. Pruvot S,
    206. Roudeau P,
    207. Schune MH,
    208. Serrano J,
    209. Sordini V,
    210. Stocchi A,
    211. Wormser G,
    212. Lange DJ,
    213. Wright DM,
    214. Bingham I,
    215. Burke JP,
    216. Chavez CA,
    217. Fry JR,
    218. Gabathuler E,
    219. Gamet R,
    220. Hutchcroft DE,
    221. Payne DJ,
    222. Touramanis C,
    223. Bevan AJ,
    224. Clarke CK,
    225. George KA,
    226. Di Lodovico F,
    227. Sacco R,
    228. Sigamani M,
    229. Cowan G,
    230. Flaecher HU,
    231. Hopkins DA,
    232. Paramesvaran S,
    233. Salvatore F,
    234. Wren AC,
    235. Davis CL,
    236. Denig AG,
    237. Fritsch M,
    238. Gradl W,
    239. Schott G,
    240. Alwyn KE,
    241. Bailey D,
    242. Barlow RJ,
    243. Chia YM,
    244. Edgar CL,
    245. Jackson G,
    246. Lafferty GD,
    247. West TJ,
    248. Yi JI,
    249. Anderson J,
    250. Chen C,
    251. Jawahery A,
    252. Roberts DA,
    253. Simi G,
    254. Tuggle JM,
    255. Dallapiccola C,
    256. Li X,
    257. Salvati E,
    258. Saremi S,
    259. Cowan R,
    260. Dujmic D,
    261. Fisher PH,
    262. Sciolla G,
    263. Spitznagel M,
    264. Taylor F,
    265. Yamamoto RK,
    266. Zhao M,
    267. Patel PM,
    268. Robertson SH,
    269. Lazzaro A,
    270. Lombardo V,
    271. Palombo F,
    272. Bauer JM,
    273. Cremaldi L,
    274. Godang R,
    275. Kroeger R,
    276. Sanders DA,
    277. Summers DJ,
    278. Zhao HW,
    279. Simard M,
    280. Taras P,
    281. Viaud FB,
    282. Nicholson H,
    283. De Nardo G,
    284. Lista L,
    285. Monorchio D,
    286. Onorato G,
    287. Sciacca C,
    288. Raven G,
    289. Snoek HL,
    290. Jessop CP,
    291. Knoepfel KJ,
    292. Losecco JM,
    293. Wang WF,
    294. Benelli G,
    295. Corwin LA,
    296. Honscheid K,
    297. Kagan H,
    298. Kass R,
    299. Morris JP,
    300. Rahimi AM,
    301. Regensburger JJ,
    302. Sekula SJ,
    303. Wong QK,
    304. Blount NL,
    305. Brau J,
    306. Frey R,
    307. Igonkina O,
    308. Kolb JA,
    309. Lu M,
    310. Rahmat R,
    311. Sinev NB,
    312. Strom D,
    313. Strube J,
    314. Torrence E,
    315. Castelli G,
    316. Gagliardi N,
    317. Margoni M,
    318. Morandin M,
    319. Posocco M,
    320. Rotondo M,
    321. Simonetto F,
    322. Stroili R,
    323. Voci C,
    324. Del Amo Sanchez P,
    325. Ben-Haim E,
    326. Briand H,
    327. Calderini G,
    328. Chauveau J,
    329. David P,
    330. Del Buono L,
    331. Hamon O,
    332. Leruste P,
    333. Ocariz J,
    334. Perez A,
    335. Prendki J,
    336. Sitt S,
    337. Gladney L,
    338. Biasini M,
    339. Covarelli R,
    340. Manoni E,
    341. Angelini C,
    342. Batignani G,
    343. Bettarini S,
    344. Carpinelli M,
    345. Cervelli A,
    346. Forti F,
    347. Giorgi MA,
    348. Lusiani A,
    349. Marchiori G,
    350. Morganti M,
    351. Neri N,
    352. Paoloni E,
    353. Rizzo G,
    354. Walsh JJ,
    355. Lopes Pegna D,
    356. Lu C,
    357. Olsen J,
    358. Smith AJ,
    359. Telnov AV,
    360. Anulli F,
    361. Baracchini E,
    362. Cavoto G,
    363. Del Re D,
    364. Di Marco E,
    365. Faccini R,
    366. Ferrarotto F,
    367. Ferroni F,
    368. Gaspero M,
    369. Jackson PD,
    370. Li Gioi L,
    371. Mazzoni MA,
    372. Morganti S,
    373. Piredda G,
    374. Polci F,
    375. Renga F,
    376. Voena C,
    377. Ebert M,
    378. Hartmann T,
    379. Schroder H,
    380. Waldi R,
    381. Adye T,
    382. Franek B,
    383. Olaiya EO,
    384. Wilson FF,
    385. Emery S,
    386. Escalier M,
    387. Esteve L,
    388. Ganzhur SF,
    389. Hamel de Monchenault G,
    390. Kozanecki W,
    391. Vasseur G,
    392. Yeche C,
    393. Zito M,
    394. Chen XR,
    395. Liu H,
    396. Park W,
    397. Purohit MV,
    398. White RM,
    399. Wilson JR,
    400. Allen MT,
    401. Aston D,
    402. Bartoldus R,
    403. Bechtle P,
    404. Benitez JF,
    405. Bertsche K,
    406. Cai Y,
    407. Cenci R,
    408. Coleman JP,
    409. Convery MR,
    410. Decker FJ,
    411. Dingfelder JC,
    412. Dorfan J,
    413. Dubois-Felsmann GP,
    414. Dunwoodie W,
    415. Ecklund S,
    416. Erickson R,
    417. Field RC,
    418. Fisher A,
    419. Fox J,
    420. Gabareen AM,
    421. Gowdy SJ,
    422. Graham MT,
    423. Grenier P,
    424. Hast C,
    425. Innes WR,
    426. Iverson R,
    427. Kaminski J,
    428. Kelsey MH,
    429. Kim H,
    430. Kim P,
    431. Kocian ML,
    432. Kulikov A,
    433. Leith DW,
    434. Li S,
    435. Lindquist B,
    436. Luitz S,
    437. Luth V,
    438. Lynch HL,
    439. Macfarlane DB,
    440. Marsiske H,
    441. Messner R,
    442. Muller DR,
    443. Neal H,
    444. Nelson S,
    445. Novokhatski A,
    446. O'Grady CP,
    447. Ofte I,
    448. Perazzo A,
    449. Perl M,
    450. Ratcliff BN,
    451. Rivetta C,
    452. Roodman A,
    453. Salnikov AA,
    454. Schindler RH,
    455. Schwiening J,
    456. Seeman J,
    457. Snyder A,
    458. Su D,
    459. Sullivan MK,
    460. Suzuki K,
    461. Swain SK,
    462. Thompson JM,
    463. Va'vra J,
    464. Van Winkle D,
    465. Wagner AP,
    466. Weaver M,
    467. West CA,
    468. Wienands U,
    469. Wisniewski WJ,
    470. Wittgen M,
    471. Wittmer W,
    472. Wright DH,
    473. Wulsin HW,
    474. Yan Y,
    475. Yarritu AK,
    476. Yi K,
    477. Yocky G,
    478. Young CC,
    479. Ziegler V,
    480. Burchat PR,
    481. Edwards AJ,
    482. Majewski SA,
    483. Miyashita TS,
    484. Petersen BA,
    485. Wilden L,
    486. Ahmed S,
    487. Alam MS,
    488. Ernst JA,
    489. Pan B,
    490. Saeed MA,
    491. Zain SB,
    492. Spanier SM,
    493. Wogsland BJ,
    494. Eckmann R,
    495. Ritchie JL,
    496. Ruland AM,
    497. Schilling CJ,
    498. Schwitters RF,
    499. Drummond BW,
    500. Izen JM,
    501. Lou XC,
    502. Bianchi F,
    503. Gamba D,
    504. Pelliccioni M,
    505. Bomben M,
    506. Bosisio L,
    507. Cartaro C,
    508. Della Ricca G,
    509. Lanceri L,
    510. Vitale L,
    511. Azzolini V,
    512. Lopez-March N,
    513. Martinez-Vidal F,
    514. Milanes DA,
    515. Oyanguren A,
    516. Albert J,
    517. Banerjee S,
    518. Bhuyan B,
    519. Choi HH,
    520. Hamano K,
    521. Kowalewski R,
    522. Lewczuk MJ,
    523. Nugent IM,
    524. Roney JM,
    525. Sobie RJ,
    526. Gershon TJ,
    527. Harrison PF,
    528. Ilic J,
    529. Latham TE,
    530. Mohanty GB,
    531. Band HR,
    532. Chen X,
    533. Dasu S,
    534. Flood KT,
    535. Pan Y,
    536. Pierini M,
    537. Prepost R,
    538. Vuosalo CO,
    539. Wu SL
    : Measurement of the e;{+}e;{-}-->bb[over] cross section between sqrt[s]=10.54 and 11.20 gev. Phys Rev Lett 102(1): 012001, 2009.
    OpenUrlPubMed
  4. ↵
    1. Minagar S,
    2. Wang J,
    3. Berndt CC,
    4. Ivanova EP,
    5. Wen C
    : Cell response of anodized nanotubes on titanium and titanium alloys. J Biomed Mater Res A 101(9): 2726-2739, 2013.
    OpenUrlPubMed
    1. Hornberger H,
    2. Virtanen S,
    3. Boccaccini AR
    : Biomedical coatings on magnesium alloys – a review. Acta Biomater 8(7): 2442-2455, 2012.
    OpenUrlCrossRefPubMed
    1. Junker R,
    2. Dimakis A,
    3. Thoneick M,
    4. Jansen JA
    : Effects of implant surface coatings and composition on bone integration: A systematic review. Clin Oral Implants Res 20(Suppl 4): 185-206, 2009.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Lincks J,
    2. Boyan BD,
    3. Blanchard CR,
    4. Lohmann CH,
    5. Liu Y,
    6. Cochran DL,
    7. Dean DD,
    8. Schwartz Z
    : Response of mg63 osteoblast-like cells to titanium and titanium alloy is dependent on surface roughness and composition. Biomaterials 19(23): 2219-2232, 1998.
    OpenUrlCrossRefPubMed
    1. López-Píriz R,
    2. Solá-Linares E,
    3. Granizo JJ,
    4. Díaz-Güemes I,
    5. Enciso S,
    6. Bartolomé JF,
    7. Cabal B,
    8. Esteban-Tejeda L,
    9. Torrecillas R,
    10. Moya JS
    : Radiologic evaluation of bone loss at implants with biocide coated titanium abutments: A study in the dog. PloS One 7(12): e52861, 2012.
    OpenUrlPubMed
  6. ↵
    1. Martinez A,
    2. Guitián F,
    3. López-Píriz R,
    4. Bartolomé JF,
    5. Cabal B,
    6. Esteban-Tejeda L,
    7. Torrecillas R,
    8. Moya JS
    : Bone loss at implant with titanium abutments coated by soda lime glass containing silver nanoparticles: A histological study in the dog. PloS One 9(1): e86926, 2014.
    OpenUrlPubMed
  7. ↵
    1. Ramaglia L,
    2. Capece G,
    3. Di Spigna G,
    4. Bruno MP,
    5. Buonocore N,
    6. Postiglione L
    : Effects of titanium surface topography on morphology and in vitro activity of human gingival fibroblasts. Minerva stomatol 62(7-8): 267-280, 2013.
    OpenUrlPubMed
  8. ↵
    1. Salerno M,
    2. Caneva-Soumetz F,
    3. Pastorino L,
    4. Patra N,
    5. Diaspro A,
    6. Ruggiero C
    : Adhesion and proliferation of osteoblast-like cells on anodic porous alumina substrates with different morphology. IEEE Trans Nanobiosci 12(2): 106-111, 2013.
    OpenUrl
    1. Wang L,
    2. Zheng W,
    3. Ding XY,
    4. Yu JK,
    5. Jiang WZ,
    6. Zhang SZ
    : Identification biomarkers of eutopic endometrium in endometriosis using artificial neural networks and protein fingerprinting. Fertil Steril 93(7): 2460-2462, 2010.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Xu JL,
    2. Zhong ZC,
    3. Yu DZ,
    4. Liu F,
    5. Luo JM
    : Effect of micro-arc oxidation surface modification on the properties of the niti shape memory alloy. J Mater Sci Mater Med 23(12): 2839-2846, 2012.
    OpenUrlPubMed
  10. ↵
    1. Jung O,
    2. Smeets R,
    3. Porchetta D,
    4. Kopp A,
    5. Ptock C,
    6. Muller U,
    7. Heiland M,
    8. Schwade M,
    9. Behr B,
    10. Kroger N,
    11. Kluwe L,
    12. Hanken H,
    13. Hartjen P
    : Optimized in vitro procedure for assessing the cytocompatibility of magnesium-based biomaterials. Acta Biomater 23: 354-363, 2015.
    OpenUrlPubMed
  11. ↵
    1. Lepore S,
    2. Milillo L,
    3. Trotta T,
    4. Castellani S,
    5. Porro C,
    6. Panaro MA,
    7. Santarelli A,
    8. Bambini F,
    9. Lo Muzio L,
    10. Conese M,
    11. Maffione AB
    : Adhesion and growth of osteoblast-like cells on laser-engineered porous titanium surface: Expression and localization of n-cadherin and beta-catenin. J Biol Regul Homeost Agents 27(2): 531-541, 2013.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

In Vivo
Vol. 30, Issue 1
January-February 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
PEO-generated Surfaces Support Attachment and Growth of Cells In Vitro with No Additional Benefit for Micro-roughness in Sa (0.2-4 μm)
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
PEO-generated Surfaces Support Attachment and Growth of Cells In Vitro with No Additional Benefit for Micro-roughness in Sa (0.2-4 μm)
OLE JUNG, RALF SMEETS, ALEXANDER KOPP, DARIO PORCHETTA, PHILIPP HIESTER, MAX HEILAND, REINHARD E. FRIEDRICH, CLARISSA PRECHT, HENNING HANKEN, ALEXANDER GRÖBE, PHILIP HARTJEN
In Vivo Jan 2016, 30 (1) 27-33;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
PEO-generated Surfaces Support Attachment and Growth of Cells In Vitro with No Additional Benefit for Micro-roughness in Sa (0.2-4 μm)
OLE JUNG, RALF SMEETS, ALEXANDER KOPP, DARIO PORCHETTA, PHILIPP HIESTER, MAX HEILAND, REINHARD E. FRIEDRICH, CLARISSA PRECHT, HENNING HANKEN, ALEXANDER GRÖBE, PHILIP HARTJEN
In Vivo Jan 2016, 30 (1) 27-33;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • In Vitro and In Vivo Biocompatibility Analysis of a New Transparent Collagen-based Wound Membrane for Tissue Regeneration in Different Clinical Indications
  • The Condensation of Collagen Leads to an Extended Standing Time and a Decreased Pro-inflammatory Tissue Response to a Newly Developed Pericardium-based Barrier Membrane for Guided Bone Regeneration
  • Plasma Electrolytic Oxidation of Titanium Implant Surfaces: Microgroove-Structures Improve Cellular Adhesion and Viability
  • Cytocompatibility of Direct Laser Interference-patterned Titanium Surfaces for Implants
  • Google Scholar

More in this TOC Section

  • Microarray Analysis of Human Abdominal Aortic Aneurysm With Emphasis on Cardiovascular Genes Revealed Differentially Expressed Genes
  • High Albumin Expression Promotes Tumor Progression in Gastric Adenocarcinoma
  • Live Porphyromonas gingivalis and Candida albicans Synergistically Induce RANKL in Osteoblast-like PDLFs But Not in Undifferentiated PDLFs
Show more Experimental Studies

Keywords

  • Plasma electrolytic oxidation
  • PEO
  • roughness
  • surface topography
  • cell adhesion
  • cell growth
In Vivo

© 2026 In Vivo

Powered by HighWire